Family Dollar Recalls 435 Consumer Health, Personal Care Products Due To Storage Temps

Firms says products recalled were “inadvertently shipped to certain stores” after “being stored outside of labeled temperature requirements." Recalls include oral products and nasal sprays, oral care products, sunscreen and other topicals, supplements and variety of personal care SKUs.

• Source: Shutterstock

Family Dollar Distribution Inc. is recalling 435 consumer health and personal care products shipped from facilities where temperatures weren't appropriate for storage, one of the problems the Food and Drug Administration reported finding in January at the US discount retail chain’s warehouse in Arkansas.

More from Retail

Germans Favor Bricks-And-Mortar Pharmacy Over Mail-Order For OTCs

 
• By 

Almost two thirds (62%) of respondents to an online survey said they would rather buy non-prescription medicines in a local pharmacy than via a mail-order pharmacy, Pharma Deutschland reports.

JCPenney’s Online Beauty Shopper Conversion, Order Value Jump Thanks To Virtual Try-On

 

Retailer JC Penney Company, Inc.’s use of Revieve Inc.’s virtual try-on and beauty advisor tools has driven significant increases in online engagement, average order rates and conversion rates for makeup, skin and hair care versus the retailer’s other e-commerce products.

False Advertising Challenges To OTC Phenylephrine Efficacy Ineffective Against Federal Preemption

 

Although FDA concluded OTC oral phenylephrine is ineffective as a nasal decongestant in doses up to highest studied level, federal preemption precludes challenges to agency’s regulation of labeling for phenylephrine and other Rx and OTC drugs, according to recent decision in New York federal court.

Bausch + Lomb Results Enhance Acquisition Image

 

Firm’s future, as a separate business nearly 90% owned by Bausch Health, or as a standalone with different ownership or one not controlled by a majority owner, claims high profile in analysts’ comments and predictions. B+L is in the driver’s seat, they say.

More from Business

New Product Launches Ensured Growth For Stada CHC In 2024

 
• By 

Like many European firms, Stada Arzneimittel's 2024 earnings were held back by a soft cough, cold and flu season. However, key launches in its home market Germany and in the Middle East offset this impact and led to 3% organic growth for Stada's Consumer Healthcare business.

Bayer Consumer Health Outlook Accelerated By ‘Dynamic’ Cuts To Staff Layers, Efficiency Boost

 

Key growth driver in consumer health and across Bayer’s sectors, says CEO Bill Anderson, is “dynamic shared ownership program” introduced in January 2024 to "reduce hierarchies, eliminate bureaucracy, streamline structures and accelerate decision-making processes."

Maxwellia Launches UK TV Campaign For Evana Showing Reality Of Menstruation

 
• By 

Maxwellia's “bold, honest, and completely unfiltered” campaign for Evana menstrual health brand tells the story of a woman dealing with the realities of a heavy period, showing “real blood, real leaks.”